Prasad, P., & Prasad, M. (2024). In Reply: Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease? Cleveland Clinic Journal of Medicine, 91(2), 82.2-83. https://doi.org/10.3949/ccjm.91c.02002

Sekerak, R., Lerner, J. B.-A., Prasad, P., & Prasad, M. (2023). Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease? Cleveland Clinic Journal of Medicine, 90(10), 607–609. https://doi.org/10.3949/ccjm.90a.23004

Rizvi, A., Sethi, A., Poneros, J., & Visrodia, K. H. (2022). Does incidentally detected common bile duct dilation need evaluation? Cleveland Clinic Journal of Medicine, 89(6), 315–319. https://doi.org/10.3949/ccjm.89a.21029